Table 3.
JTTZ group | Metformin group | P values | |
---|---|---|---|
Total symptom score | |||
Week 0 | 11.03 ± 4.93 | 10.78 ± 4.63 | 0.598 |
Week 12 | 5.80 ± 4.05 | 8.57 ± 4.40 | 0.000 |
Week 12–week 0 | −5.23 ± 4.20 | −2.21 ± 4.11 | 0.000 |
Paired sample t-test (P) | 0.000 | 0.000 | |
Symptom disappearance rate | |||
Thoracoabdominal distension | 55 (44.4%) | 35 (27.8%) | 0.006 |
Abdominal fullness | 74 (54.8%) | 52 (46.0%) | 0.168 |
Constipation | 62 (72.9%) | 26 (31.7%) | 0.000 |
Dry mouth | 55 (33.7%) | 41 (25.9%) | 0.128 |
Bitter mouth | 49 (41.2%) | 33 (28.4%) | 0.041 |
Halitosis | 46 (45.1%) | 18 (21.7%) | 0.001 |
Thirst and drinking cold water | 35 (29.4%) | 28 (25.0%) | 0.453 |
Increased eating with rapid hunger | 57 (46.7%) | 33 (30.8%) | 0.014 |
Red tongue and yellow tongue coating | 51 (29.8%) | 28 (18.8%) | 0.023 |
Power and rapid pulse | 71 (50.0%) | 34 (27.6%) | 0.000 |